[Diagnostic issues of Whipple's disease during chronic inflammatory rheumatism: About three cases]

Rev Med Interne. 2021 Nov;42(11):801-804. doi: 10.1016/j.revmed.2021.06.009. Epub 2021 Jul 1.
[Article in French]

Abstract

Introduction: Whipple's disease (WD) can mimic chronic inflammatory rheumatism leading to incorrect prescription of tumor necrosis factor inhibitors (TNFI). Several complicated cases of WD have been reported during TNFI treatment which is strongly suspected to modify the host-pathogen relationship. Tropheryma whipplei asymptomatic carriage is high in the general population, making the diagnosis of WD more difficult face to unexplained arthritis.

Observations: We report three observations that illustrate situations for which the detection of T. whipplei might be valuable to investigate the differential diagnosis of inflammatory rheumatism.

Conclusion: The decision to check for T. whipplei infection should rely on individual clinical assessment. It should be considered in the absence of clinical response or in case of worsening of an inflammatory rheumatism under TNFI treatment, especially in front of atypical features. A systematic screening for T. whipplei before anti-TNF treatment seems unjustified since asymptomatic carriers are frequent.

Keywords: Anti-TNF; Arthritis; DMARDs; Maladie de Whipple; Polyarthrite; Tropheryma whipplei; Tumor necrosis factor inhibitors; Whipple's disease.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Humans
  • Rheumatic Fever* / drug therapy
  • Tropheryma
  • Tumor Necrosis Factor Inhibitors
  • Whipple Disease* / complications
  • Whipple Disease* / diagnosis
  • Whipple Disease* / drug therapy

Substances

  • Anti-Bacterial Agents
  • Tumor Necrosis Factor Inhibitors